Protalix BioTherapeutics
PLX
#8974
Rank
NZ$0.32 B
Marketcap
NZ$4.00
Share price
-0.65%
Change (1 day)
64.69%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): NZ$0.02662

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is NZ$0.03503. In 2024 the company made an earnings per share (EPS) of NZ$0.07007 a decrease over its 2023 EPS that were of NZ$0.21.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$0.02662-62%
2024NZ$0.07007-66.67%
2023NZ$0.21-138.71%
2022NZ-$0.54-50%
2021NZ-$1.09181.82%
2020NZ-$0.39-82.11%
2019NZ-$2.15-31.67%
2018NZ-$3.15-72.31%
2017NZ-$11.39124.14%
2016NZ-$5.08-147.54%
2015NZ$10.69-290.63%
2014NZ-$5.616.67%
2013NZ-$5.26130.77%
2012NZ-$2.28-69.77%
2011NZ-$7.5319.44%
2010NZ-$6.31-12.2%
2009NZ-$7.1836.67%
2008NZ-$5.26-37.5%
2007NZ-$8.4150%
2006NZ-$5.613.23%
2005NZ-$5.43138.46%
2004NZ-$2.28-74%
2003NZ-$8.76-0%
2002NZ-$8.76-50%
2001NZ-$17.52233.33%
2000NZ-$5.26-84.21%
1999NZ-$33.28-24%
1998NZ-$43.79-600%
1997NZ$8.76-16.67%
1996NZ$10.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.29 6,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$11.75 33,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ-$0.19-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.40 6,750.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel